Corline Biomedical AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 10.2 million compared to SEK 4.42 million a year ago. Revenue was SEK 10.21 million compared to SEK 4.53 million a year ago.

Net income was SEK 1.02 million compared to net loss of SEK 0.852 million a year ago. Basic earnings per share from continuing operations was SEK 0.05 compared to basic loss per share from continuing operations of SEK 0.04 a year ago. Diluted earnings per share from continuing operations was SEK 0.05 compared to diluted loss per share from continuing operations of SEK 0.04 a year ago.